Thomas F. Munzel
Experienced in Age-Related Macular Degeneration (ARMD)

Thomas F. Munzel

Untere Zahlbacher Str. 8, 
Mainz, RP, DE 
Experienced in Age-Related Macular Degeneration (ARMD)
Untere Zahlbacher Str. 8, 
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Thomas Munzel practices in Mainz, Germany. Mr. Munzel is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Pulmonary Embolism, Heart Attack, Mesenteric Venous Thrombosis, Percutaneous Coronary Intervention (PCI), and Stent Placement.

His clinical research consists of co-authoring 923 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Untere Zahlbacher Str. 8, Mainz, RP 55131, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction
Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction
Enrollment Status: Completed
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 1/Phase 2
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC)
Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

922 Total Publications

Altered Neuroretinal Tissue in Childhood Cancer Survivors: Data From the German CVSS Study.
Altered Neuroretinal Tissue in Childhood Cancer Survivors: Data From the German CVSS Study.
Journal: Translational vision science & technology
Published: October 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Munzel's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 10 Distinguished Conditions
View All 29 Advanced Conditions
View All 66 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile